SaTH achieves record 62-day cancer referral to treatment rate
By Lee Peart 22 October 2026
The Shrewsbury and Telford Hospital NHS Trust (SaTH), part of Shropshire, Telford and Wrekin Community and Hospitals NHS Group, has delivered its best-ever 62-day referral to treatment performance ...
'Wake-up call' as 'concerning' increase in under 50s cancer revealed
By Lee Peart 06 October 2026
Statistics revealing a sharp rise in cancer rates in the under 50s, including a more than tripling of prostate cancer, have been described as a ‘wake-up call’.
Rapid genomic test to transform brain tumour diagnosis
By Lee Peart 25 September 2026
A rapid genomic test for brain tumours developed at University of Nottingham and Nottingham University Hospitals NHS Trust is being extended across specialist centres in England.
Progress on National Cancer Plan to be scrutinised
By Lee Peart 21 September 2026
Progress on the National Cancer Plan is to be scrutinised by the first meeting of the National Cancer Board today.
Breast services review to take place following shocking revelations
By Lee Peart 21 September 2026
An extraordinary meeting will be held this week following shocking revelations that 20 women needlessly had their breasts removed while under the care of County Durham and Darlington NHS Foundation...
Cancer patients rate NHS care nine out of 10 as record numbers treated
By Lee Peart 16 July 2026
Cancer patients have rated their NHS care as almost nine out of 10 as record numbers receive treatment.
Trust 'beginning to make a difference' on breast cancer diagnosis delays
By Lee Peart 30 June 2026
County Durham and Darlington NHS Foundation Trust (CDDFT) has said it is ‘beginning to make a difference on reducing breast cancer diagnosis delays.
Men with early prostate cancer to be offered precision radiotherapy
By Lee Peart 10 June 2026
A high-powered ‘precision’ radiotherapy known as SABR (stereotactic ablative radiotherapy) is to be offered to eligible men with early prostate cancer for the first time by the NHS.
Hundreds of patients to benefit from ovarian cancer drug
By Lee Peart 04 June 2026
Hundreds of patients with ovarian cancer could benefit from a life-extending drug on the NHS from today.
Blood test helps reduce late-stage cancer diagnosis
By Lee Peart 01 June 2026
The use of a blood test when combined with existing NHS screening can help reduce late stage cancer diagnosis, research has found.
Macmillan launches £30m investment fund
By Lee Peart 20 May 2026
Macmillan Cancer Support has launched a £30m investment fund to help transform care for people living with cancer in the UK.
Supported Accommodation Officer x2 Posts (CDC)
Grade 7 - £29,542 - £32,578
Doncaster, South YorkshireGrade 7 - £29,542 - £32,578
Rehabilitation Officer / Worker Visual Impairment
£39,481 to £44,253 per annum (pro rata for part time)
Scarborough, North Yorkshire£39,481 to £44,253 per annum (pro rata for part time)
Most Read News
- New hope for personalised prostate cancer treatment
- Greater Manchester Mental Health chair to step down
- Over 80,000 children face year-long waits for community health appointments
- Bedfordshire Hospitals completes patient records digitisation
- NHS hits dementia diagnosis target for first time in six years
Supported Accommodation Officer x2 Posts (CDC)
Grade 7 - £29,542 - £32,578
Doncaster, South YorkshireGrade 7 - £29,542 - £32,578
Rehabilitation Officer / Worker Visual Impairment
£39,481 to £44,253 per annum (pro rata for part time)
Scarborough, North Yorkshire£39,481 to £44,253 per annum (pro rata for part time)
Most Read News
- New hope for personalised prostate cancer treatment
- Greater Manchester Mental Health chair to step down
- Over 80,000 children face year-long waits for community health appointments
- Bedfordshire Hospitals completes patient records digitisation
- NHS hits dementia diagnosis target for first time in six years
©2026 Hemming Group Limited. Registered in England and Wales. Registered No: 490200. VAT number GB342 023 408
